Can a natural compound help seniors survive sepsis?
NCT ID NCT05758246
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether the drug fisetin can reduce organ failure in adults aged 65 and older who have sepsis (a severe response to infection). Researchers will give participants either one or two doses of fisetin or a placebo, and measure changes in heart, lung, and kidney function over a week. The goal is to see if fisetin can help prevent the progression of sepsis to more serious organ damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fisetin (a drug given by mouth)
- What this could lead to
- If it works, this could point toward a treatment that reduces organ damage in older patients with sepsis.
- What could go wrong
- This is an early phase 2 trial with only 220 participants, so results may not apply to all sepsis patients. The drug may not improve outcomes or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HCMC
RECRUITINGMinneapolis, Minnesota, 55415, United States
-
M Health Fairview St. John's
RECRUITINGMaplewood, Minnesota, 55109, United States
-
Ridges
RECRUITINGBurnsville, Minnesota, 55337, United States
-
Southdale
RECRUITINGEdina, Minnesota, 55435, United States
-
St. John's
RECRUITINGMaplewood, Minnesota, 55109, United States
-
UMMC
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55414, United States
-
University of Mississippi Medical Center
RECRUITINGJackson, Mississippi, 39216, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?